New research to further understand the whole-body effects of weight loss drugs
New research examines the effects of glucagon receptor-targeted drugs, which are being developed for the treatment of obesity and metabolic disease.
Research into c-JUN oncoprotein could pave way for novel colon cancer therapies
A new collaborative study looks at how multiple phosphorylations of a protein can regulate the transcription of genes linked to colon cancer.
NIHR Imperial BRC Director on what £95m funding means for Imperial's community
Following the NIHR Imperial BRC funding announcement, BRC Director, Professor Mark Thursz, spoke about the application and the centre's future impact.
Molecular classification of inflammatory bowel disease
New research maps how gene expression is regulated by cytokines, paving the way for personalised medicine approaches in inflammatory bowel diseases.
Imperial researcher on the analytical science’s Top 40 Under 40 Power List 2022
A researcher in the Department of Surgery and Cancer has been recognised as one of 40 gifted young scientists making waves in analytical science.
MDR researchers celebrated latest round of academic promotions
The Department of Metabolism, Digestion & Reproduction is proud to have seven of its staff recognised in the latest round of Academic Promotions.
Unique clinical imaging dataset to accelerate diagnosis of prostate cancer
The National Cancer Imaging Translational Accelerator has released a unique clinical imaging dataset from the Prostate MRI Imaging Study (PROMIS).
New ways of tracking people’s diets tested for health benefits
Researchers will try new techniques, including wearable cameras and urine and blood tests, to more accurately measure the UK’s eating habits.
Women who freeze their eggs at 40 are unlikely to have a successful livebirth
A new study has found that women who freeze their eggs at 40 are unlikely to have a successful livebirth when they come to attempt pregnancy.
HPV vaccine alongside removal of cervical lesions may cut cervical cancer risk
A new study finds a reduced risk of cervical cancer recurring after HPV vaccination post-surgery, although further research and trials are needed.
